Matinas BioPharma Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Go back to Matinas BioPharma Reports Third Quarter 2019 Financial Results and Provides Corporate Update
(NYSE: MTNB) Delayed: 0.17 +0.01 (6.25%)
Previous Close $0.16    52 Week High $2.01 
Open $0.16    52 Week Low $0.41 
Day High $0.17    P/E N/A 
Day Low $0.16    EPS $0.00 
Volume 292,403